Benzinga | May 13, 2021 05:00PM EDT

ImmuCell Q1 EPS $(0.06) Misses $0.05 Estimate, Sales $4.11M Miss $5.40M Estimate

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.05 by 220 percent. This is a 200 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $4.11 million which missed the analyst consensus estimate of $5.40 million by 23.94 percent. This is a 16.35 percent decrease over sales of $4.91 million the same period last year.